Palatin Technologies Inc (PTN)
2.12
+0.07
(+3.41%)
USD |
NYAM |
May 03, 15:12
Palatin Technologies Accounts Payable (Quarterly): 1.594M for Dec. 31, 2023
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 1.594M |
September 30, 2023 | 2.270M |
June 30, 2023 | 4.304M |
March 31, 2023 | 2.786M |
December 31, 2022 | 0.8203M |
September 30, 2022 | 3.774M |
June 30, 2022 | 3.158M |
March 31, 2022 | 2.403M |
December 31, 2021 | 0.1602M |
September 30, 2021 | 0.7628M |
June 30, 2021 | 0.6407M |
March 31, 2021 | 0.864M |
December 31, 2020 | 1.174M |
September 30, 2020 | 0.9713M |
June 30, 2020 | 0.7157M |
March 31, 2020 | 1.612M |
December 31, 2019 | 0.1352M |
September 30, 2019 | 0.0578M |
June 30, 2019 | 0.5048M |
March 31, 2019 | 0.4748M |
December 31, 2018 | 0.6199M |
September 30, 2018 | 1.165M |
June 30, 2018 | 2.224M |
March 31, 2018 | 0.7936M |
December 31, 2017 | 0.7038M |
Date | Value |
---|---|
September 30, 2017 | 2.034M |
June 30, 2017 | 1.551M |
March 31, 2017 | 1.243M |
December 31, 2016 | 4.706M |
September 30, 2016 | 1.159M |
June 30, 2016 | 0.7139M |
March 31, 2016 | 1.783M |
December 31, 2015 | 2.376M |
September 30, 2015 | 3.437M |
June 30, 2015 | 1.106M |
March 31, 2015 | 2.326M |
December 31, 2014 | 1.914M |
September 30, 2014 | 0.5614M |
June 30, 2014 | 0.2613M |
March 31, 2014 | 0.4318M |
December 31, 2013 | 0.291M |
September 30, 2013 | 0.9909M |
June 30, 2013 | 0.3387M |
March 31, 2013 | 0.7334M |
December 31, 2012 | 0.4848M |
September 30, 2012 | 0.3216M |
June 30, 2012 | 0.2949M |
March 31, 2012 | 0.5579M |
December 31, 2011 | 0.5806M |
September 30, 2011 | 0.3362M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
0.0578M
Minimum
Sep 2019
4.304M
Maximum
Jun 2023
1.511M
Average
0.9713M
Median
Sep 2020
Accounts Payable (Quarterly) Benchmarks
Oragenics Inc | 1.245M |
Outset Medical Inc | 5.827M |
Ligand Pharmaceuticals Inc | 2.427M |
Galectin Therapeutics Inc | 6.431M |
ADMA Biologics Inc | 15.66M |